{"top_spans": [[0, 0], [1, 1], [6, 8], [6, 14], [10, 10], [11, 11], [11, 14], [14, 14], [16, 16], [20, 29], [23, 24], [23, 28], [23, 29], [24, 29], [25, 25], [25, 28], [25, 29], [30, 30], [31, 31], [33, 33], [37, 37], [38, 38], [38, 41], [38, 44], [39, 39], [41, 41], [42, 42], [42, 48], [42, 49], [44, 44], [51, 51], [57, 57], [57, 59], [58, 59], [59, 59], [63, 63], [65, 68], [70, 70], [76, 76], [85, 85], [86, 89], [94, 96], [94, 100], [98, 100], [108, 111], [115, 115], [116, 116], [118, 118], [138, 138], [138, 139], [139, 139], [140, 140], [141, 141], [141, 144], [142, 142], [143, 143], [143, 144], [145, 145], [145, 147], [145, 148], [145, 150], [146, 147], [146, 149], [146, 150], [160, 160], [166, 166], [169, 169], [171, 171]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 13, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["incyte", "announces", "positive", "interim", "data", "from", "phase", "2", "trial", "of", "pemigatinib", "its", "selective", "fgfr", "inhibitor", "in", "patients", "with", "cholangiocarcinoma", "wilmington", "del", "business", "wire", "-oct", "21", "2018-incyte", "corporation", "nasdaq", "incy", "announces", "updated", "data", "from", "its", "ongoing", "phase", "2", "fight-202", "trial", "evaluating", "pemigatinib", "incb54828", "its", "selective", "fibroblast", "growth", "factor", "receptor", "fgfr", "inhibitor", "in", "patients", "with", "advanced", "metastatic", "or", "surgically", "unresectable", "cholangiocarcinoma", "bile", "duct", "cancer", "who", "failed", "at", "least", "one", "previous", "treatment", "in", "patients", "with", "fgfr2", "translocations", "who", "were", "followed", "for", "at", "least", "eight", "months", "interim", "study", "results", "demonstrated", "an", "overall", "response", "rate", "orr", "of", "40", "percent", "the", "primary", "endpoint", "and", "a", "median", "progression", "free", "survival", "pfs", "of", "9", "2", "months", "a", "key", "secondary", "endpoint", "esmo", "abdominal", "pain", "steven", "stein", "cholangiocarcinoma", "del", "japan", "pemigatinib", "villejuif", "securities", "and", "exchange", "commission", "intrahepatic", "cholangiocarcinoma", "teaes", "france", "independent", "review", "chief", "medical", "officer", "institut", "de", "canc\u00e9rologie", "gustave", "roussy", "twitter", "europe", "wilmington", "delaware", "congress", "hypophosphatemia", "u", "s", "munich", "germany", "european", "society", "for", "medical", "oncology", "food", "and", "drug", "administration", "fda", "incyte", "corporation", "antoine", "hollebecque", "arthralgia", "wilmington", "hyperphosphatemia", "oncology", "and", "hematology", "trials", "incyte"], "clusters": [[[11, 11], [33, 33], [42, 42]]]}